The largest database of trusted experimental protocols

Quikchange 2 site

Manufactured by Agilent Technologies
Sourced in United States

The QuikChange II site is a lab equipment product from Agilent Technologies that enables the rapid and efficient introduction of site-directed mutations into double-stranded plasmid DNA. It provides a simple and reliable method for creating specific mutations, insertions, or deletions in target DNA sequences.

Automatically generated - may contain errors

5 protocols using quikchange 2 site

1

Mutagenesis and Plasmid Propagation in E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
All recombinant DNA techniques were performed according to established procedures using Escherichia coli XL1 blue cells for cloning and plasmid propagation. Mutations in hRPS14 were generated using the QuikChange II site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA, USA). All cloned DNA fragments and mutagenized plasmids were verified by sequencing. The RPS14 T133A phospho-mutant was generated by transforming JWY6851 strain64 (link)
with plasmids listed in Supplementary Data 17. pGal-yRPS14 was shuffled out on FOA plates. The plasmids used in this study are listed in Supplementary Data 17 and generated humanized yeast strains are listed in Supplementary Data 18.
+ Open protocol
+ Expand
2

Generation and Characterization of GPR15 Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
GPR15 cDNA from various species were synthesized from General Biosystems Corporation Limited (Anhui, China), and GPR15 point mutants were generated by introducing point mutations using a QuikChange II site‐directed mutagenesis kit (Agilent Technologies). Briefly, overlapping primers with the desired point mutations were used to amplify wild‐type GPR15. The parental plasmid was digested using the DpnI enzyme, and the newly synthesized plasmid was used as a template for PCR amplification of GPR15 mutants before subcloning into the pcDNA3.1‐V5‐His plasmid. Adenovirus‐based gene delivery vector was constructed by Hanbio Biotechnology Co., Ltd (http://www.hanbio.net). PGL4.14 plasmid was kindly provided by Dr. Ziqiang Zhu’s lab.
+ Open protocol
+ Expand
3

Cloning and Characterization of Antiviral Factors

Check if the same lab product or an alternative is used in the 5 most similar protocols
CH25H, IFIH1, IFITM1, IFITM2, IFITM3, and LY6E were cloned into pLX304 lentiviral vector with a C-terminal V5 tag. Human ACE2 was cloned into pDEST-mCherry vector with an N-terminal mCherry tag. TMPRSS2 and TMPRSS4 plasmids were used as previously described (18 (link)). Single-guide RNA against CH25H or NPC1 (SI Appendix, Table S1) was cloned into lenti-CRISPR_v2 vector (Addgene, #52961). CH25H point mutations were introduced by QuikChange II site-directed mutagenesis (Agilent, #200524) using primers in SI Appendix, Table S1. GFP-tagged Rab5 and Rab7 constructs were used as reported previously (64 (link)). Codon-optimized SARS-CoV-2 S was a kind gift from Nevan Krogan at the University of California, San Francisco, CA (65 (link)). pCAGGS-SARS-CoV S was a kind gift of Paul Bates at the University of Pennsylvania, Philadelphia, PA (66 (link)). pMIG-WEEV-IRES-GFP plasmid was generated by Zhuoming Liu in the S.P.J.W. laboratory at the Washington University School of Medicine in St. Louis, St. Louis, MO. PM-GFP and VSV-G plasmids were obtained from Addgene (#21213 and #12259, respectively). pCAGGS-FAST-p10 from pteropine orthoreovirus was generated in the Kobayashi laboratory at the Osaka University, Japan (67 (link)). pEGFP-N1 and pCMV-TdTomato were obtained from Clontech.
+ Open protocol
+ Expand
4

Coronavirus Spike Protein Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein sequence information used in this study was provided in S1 Table. Expression plasmids of coronavirus spike proteins or ACE2 proteins and variants were created by synthesizing fragments by Integrated DNA Technologies (IDT, Coralville, IA, USA), and ligating them into pCAGGS or pcDNA vector respectively using In-Fusion HD Cloning Kit (Takara Bio USA) according to manufacturer’s instructions. ACE2-Fc variants were generated by the QuikChange II site-directed mutagenesis protocol (Agilent). The plasmid expressing human DPP4 is a gift from Dr. Bart L. Haagmans.
+ Open protocol
+ Expand
5

Mutagenesis and Plasmid Propagation in E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
All recombinant DNA techniques were performed according to established procedures using Escherichia coli XL1 blue cells for cloning and plasmid propagation. Mutations in hRPS14 were generated using the QuikChange II site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA, USA). All cloned DNA fragments and mutagenized plasmids were verified by sequencing. The RPS14 T133A phospho-mutant was generated by transforming JWY6851 strain64 (link)
with plasmids listed in Supplementary Data 17. pGal-yRPS14 was shuffled out on FOA plates. The plasmids used in this study are listed in Supplementary Data 17 and generated humanized yeast strains are listed in Supplementary Data 18.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!